Veklury 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FY5BU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,903
Award facts
- Contract value 100% obligated
- $12,903.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,903.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Veklury 100 mg vials, with a completion deadline of January 30, 2026. This non-set-aside competitive award represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems, and this delivery order is to be performed at the company's corporate office location in Conshohocken, PA.
Veklury (remdesivir) is an antiviral medication used to treat serious viral infections. This small-value delivery order exemplifies the routine pharmaceutical procurement that occurs under DLA's broader prime vendor contract vehicle, which supports military healthcare programs globally with a diverse range of medications, vaccines, medical devices, and specialized healthcare commodities. AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which operates under the AmerisourceBergen business name, holds the primary IDC and has demonstrated substantial capability in fulfilling federal pharmaceutical supply requirements through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DR26FY5BU?
SPE2DR26FY5BU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FY5BU worth?
The government has obligated $12,903 on SPE2DR26FY5BU.
Is contract SPE2DR26FY5BU an order under another contract?
Yes. SPE2DR26FY5BU is a delivery order under SPE2DR25D1056, an indefinite delivery contract.
Was contract SPE2DR26FY5BU competed?
The extent of competition for SPE2DR26FY5BU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award